Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific PSG1 CD66f, PBG1, PSBG1, PSGGA ENSG00000231924 Pregnancy specific beta-1-glycoprotein 1 19 42866464-42879822 CD markers, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046327 Approved Tissue enriched 383 placenta: 362.6 smooth muscle: 0.9 CSHL1 CS-5, CSHP1, CSL, hCS-L, MGC149868 ENSG00000204414 Chorionic somatomammotropin hormone-like 1 17 63909597-63918838 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level CAB025646, HPA043715 Supported Tissue enriched 356 placenta: 216.4 smooth muscle: 0.6 PSG2 CEA, PSBG2, PSG1, PSGGB ENSG00000242221 Pregnancy specific beta-1-glycoprotein 2 19 43064211-43083045 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 229 placenta: 342.1 smooth muscle: 1.4 CSH1 CSA, CSMT, FLJ75407, hCS-A, PL ENSG00000136488 Chorionic somatomammotropin hormone 1 (placental lactogen) 17 63894909-63896661 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026374, HPA043715 Supported Tissue enriched 214 placenta: 13476.0 smooth muscle: 63.0 HBG1 HBG-T2 ENSG00000213934 Hemoglobin, gamma A 11 5248083-5249892 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043234 Approved Tissue enriched 213 placenta: 253.1 spleen: 1.1 GH2 GH-V , GH2, GHL, GHV, hGH-V ENSG00000136487 Growth hormone 2 17 63880215-63881935 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043715 Supported Tissue enriched 202 placenta: 189.0 smooth muscle: 0.9 CSH2 CS-2, CSB, hCS-B ENSG00000213218 Chorionic somatomammotropin hormone 2 17 63872012-63881863 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA043715 Supported Tissue enriched 195 placenta: 3928.4 smooth muscle: 20.1 XAGE3 CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3 ENSG00000171402 X antigen family, member 3 X 52862525-52868068 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA052507, HPA059045, HPA060900 Approved Tissue enriched 165 placenta: 571.7 adipose tissue: 3.4 PSG3 ENSG00000221826 Pregnancy specific beta-1-glycoprotein 3 19 42721638-42740569 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA046327 Approved Tissue enriched 161 placenta: 188.4 testis: 1.1 HBG2 HBG-T1 ENSG00000196565 Hemoglobin, gamma G 11 5248274-5645789 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016143, HPA043234 Approved Approved Vesicles Tissue enriched 126 placenta: 20295.9 bone marrow: 160.6 PSG9 PSG11, PSGII ENSG00000183668 Pregnancy specific beta-1-glycoprotein 9 19 43211791-43269530 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA046327 Approved Tissue enriched 120 placenta: 146.9 smooth muscle: 1.2 ISM2 FLJ32147, TAIL1, THSD3 ENSG00000100593 Isthmin 2 14 77474394-77498850 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA039314, HPA039742 Supported Supported Nucleoplasm Tissue enriched 114 placenta: 272.7 epididymis: 2.3 PSG5 FL-NCA-3, PSG ENSG00000204941 Pregnancy specific beta-1-glycoprotein 5 19 43166256-43186536 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046327 Approved Tissue enriched 107 placenta: 157.4 smooth muscle: 1.4 ERVV-2 ENSG00000268964 Endogenous retrovirus group V, member 2 19 53044738-53051076 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 99 placenta: 13.5 testis: 0.1 CGB8 ENSG00000213030 Chorionic gonadotropin, beta polypeptide 8 19 49047638-49049106 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038925, HPA038934 Supported Approved Cytosol Tissue enriched 92 placenta: 29.2 parathyroid gland: 0.3 KISS1 ENSG00000170498 KiSS-1 metastasis-suppressor 1 204190341-204196486 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017775, HPA035542 Supported Approved Vesicles Tissue enriched 86 placenta: 328.0 stomach: 3.8 PSG11 MGC22484, PSG13, PSG14 ENSG00000243130 Pregnancy specific beta-1-glycoprotein 11 19 43007656-43026512 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA042240, HPA046327 Supported Tissue enriched 78 placenta: 73.9 smooth muscle: 0.9 PSG6 ENSG00000170848 Pregnancy specific beta-1-glycoprotein 6 19 42902079-42919563 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA046327 Approved Tissue enriched 75 placenta: 70.1 bone marrow: 0.9 CGB5 HCG ENSG00000189052 Chorionic gonadotropin, beta polypeptide 5 19 49043884-49045311 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038925, HPA038934 Supported Approved Cytosol Tissue enriched 67 placenta: 31.7 testis: 0.4 ERVV-1 ENVV1, FLJ32214, HERV-V1 ENSG00000269526 Endogenous retrovirus group V, member 1 19 53013921-53016122 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 65 placenta: 21.9 prostate: 0.3 LGALS14 CLC2, PPL13 ENSG00000006659 Lectin, galactoside-binding, soluble, 14 19 39704306-39709444 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 57 placenta: 69.0 skin: 1.2 NOTUM ENSG00000185269 Notum pectinacetylesterase homolog (Drosophila) 17 81952507-81961840 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 56 placenta: 191.3 liver: 3.4 LGALS16 ENSG00000249861 Lectin, galactoside-binding, soluble, 16 19 39655894-39660647 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 53 placenta: 7.6 testis: 0.1 FAM26D C6orf78, FLJ32239 ENSG00000164451 Family with sequence similarity 26, member D 6 116529013-116558868 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 46 placenta: 33.6 testis: 0.7 AC104389.1 ENSG00000279346 11 5253367-5254782 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enriched 39 placenta: 11.1 cerebral cortex: 0.2 LGALS13 PLAC8, PP13 ENSG00000105198 Lectin, galactoside-binding, soluble, 13 19 39602501-39607476 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 35 placenta: 16.5 testis: 0.4 XAGE2 CT12.2, GAGED3, XAGE-2, XAGE2B ENSG00000155622 X antigen family, member 2 X 52369030-52375680 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA052507, HPA060900 Supported Tissue enriched 35 placenta: 292.4 lung: 8.4 EGFL6 MAEG ENSG00000198759 EGF-like-domain, multiple 6 X 13569605-13633575 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA001838 Approved Tissue enriched 34 placenta: 913.7 lung: 26.8 PRG2 BMPG, MBP ENSG00000186652 Proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) 11 57386794-57390657 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038515 Supported Tissue enriched 29 placenta: 3847.6 bone marrow: 130.5 SIGLEC6 CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6 ENSG00000105492 Sialic acid binding Ig-like lectin 6 19 51519525-51531856 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009084, HPA018198 Supported Tissue enriched 24 placenta: 147.1 lung: 6.0 HLA-G ENSG00000204632 Major histocompatibility complex, class I, G 6 29826967-29831125 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016158 Supported Tissue enriched 23 placenta: 14.8 testis: 0.6 TFPI2 PP5, REF1, TFPI-2 ENSG00000105825 Tissue factor pathway inhibitor 2 7 93885397-93890991 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010142, HPA049158 Supported Tissue enriched 23 placenta: 1205.5 ovary: 52.0 CGA FSHA, GPHa, GPHA1, HCG, LHA, TSHA ENSG00000135346 Glycoprotein hormones, alpha polypeptide 6 87085498-87095406 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB023350, HPA029698 Supported Tissue enriched 22 placenta: 652.2 stomach: 29.5 TAC3 NKB, NKNB, ZNEUROK1 ENSG00000166863 Tachykinin 3 12 57010000-57028883 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045919 Supported Tissue enriched 22 placenta: 610.5 cerebral cortex: 27.3 AC104389.2 ENSG00000279824 11 5248449-5249858 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enriched 21 placenta: 2.6 liver: 0.1 GCM1 GCMA, hGCMa ENSG00000137270 Glial cells missing homolog 1 (Drosophila) 6 53126964-53148829 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA011343 Supported Approved Vesicles Tissue enriched 21 placenta: 29.0 kidney: 1.4 PLAC1 CT92, OOSP2L ENSG00000170965 Placenta-specific 1 X 134565838-134764322 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA063425 Supported Tissue enriched 21 placenta: 37.6 testis: 1.7 HTRA4 FLJ90724 ENSG00000169495 HtrA serine peptidase 4 8 38974164-38988662 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045402 Approved Tissue enriched 20 placenta: 94.4 bone marrow: 4.8 CGB CGB3 ENSG00000104827 Chorionic gonadotropin, beta polypeptide 19 49022869-49024333 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB000042, CAB010884, HPA038925, HPA038934 Supported Approved Cytosol Tissue enriched 18 placenta: 14.9 testis: 0.8 IGF2 C11orf43, FLJ44734, IGF-II ENSG00000167244 Insulin-like growth factor 2 11 2129112-2141238 Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007556, HPA007993 Supported Approved Nucleoplasm
Vesicles Tissue enriched 18 placenta: 3974.6 fallopian tube: 220.1 KRTAP26-1 ENSG00000197683 Keratin associated protein 26-1 21 30319124-30320316 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 18 placenta: 1.9 testis: 0.1 ADAMTS18 ADAMTS21 ENSG00000140873 ADAM metallopeptidase with thrombospondin type 1 motif, 18 16 77247813-77435114 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA044326 Uncertain Tissue enriched 16 placenta: 28.9 cervix: 1.8 FCGR2B CD32, CD32B, FCG2, FCGR2 ENSG00000072694 Fc fragment of IgG, low affinity IIb, receptor (CD32) 1 161663147-161678654 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007796, HPA014730 Supported Tissue enriched 16 placenta: 571.2 adipose tissue: 36.3 HGF DFNB39, F-TCF, HGFB, HPTA, SF ENSG00000019991 Hepatocyte growth factor (hepapoietin A; scatter factor) 7 81699006-81770438 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010333, HPA040360, HPA044088 Approved Approved Centrosome
Cytosol Tissue enriched 16 placenta: 435.4 gallbladder: 27.6 CYP19A1 ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM ENSG00000137869 Cytochrome P450, family 19, subfamily A, polypeptide 1 15 51208057-51338610 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000355, HPA051194 Supported Approved Vesicles Tissue enriched 14 placenta: 173.9 testis: 12.4 HSD17B1 EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1 ENSG00000108786 Hydroxysteroid (17-beta) dehydrogenase 1 17 42549214-42555213 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021032, HPA065296 Supported Supported Cytosol Tissue enriched 14 placenta: 98.3 cerebral cortex: 7.1 LIN28B CSDD2, FLJ16517 ENSG00000187772 Lin-28 homolog B (C. elegans) 6 104957048-105083332 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036630, HPA061745 Supported Supported Nucleus
Nucleoli
Cytosol Tissue enriched 13 placenta: 67.2 testis: 5.3 TRIM64B ENSG00000189253 Tripartite motif containing 64B 11 89869282-89876017 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA045370 Approved Tissue enriched 13 placenta: 3.0 epididymis: 0.2 VGLL1 TDU, TONDU ENSG00000102243 Vestigial-like family member 1 X 136532152-136556807 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA042403, HPA064616 Supported Supported Nucleus Tissue enriched 13 placenta: 255.8 urinary bladder: 19.0 C4orf26 FLJ23657 ENSG00000174792 Chromosome 4 open reading frame 26 4 75556048-75565885 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 12 placenta: 5.8 cerebral cortex: 0.5 HSD3B1 HSD3B, HSDB3, SDR11E1 ENSG00000203857 Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 1 119507198-119515054 Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043261, HPA043264, HPA044028 Supported Tissue enriched 12 placenta: 110.1 small intestine: 8.9 IL1RL1 DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1 ENSG00000115602 Interleukin 1 receptor-like 1 2 102311502-102352037 Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007406, HPA007917 Uncertain Approved Vesicles Tissue enriched 12 placenta: 286.6 gallbladder: 23.8 INSL4 EPIL ENSG00000120211 Insulin-like 4 (placenta) 9 5231419-5235304 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 12 placenta: 22.2 epididymis: 1.8 PSG8 ENSG00000124467 Pregnancy specific beta-1-glycoprotein 8 19 42752686-42855691 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA046327 Approved Tissue enriched 12 placenta: 9.1 parathyroid gland: 0.7 CHAT ENSG00000070748 Choline O-acetyltransferase 10 49609095-49665104 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002313, HPA048547 Supported Tissue enriched 11 placenta: 7.1 duodenum: 0.6 ERVW-1 ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW ENSG00000242950 Endogenous retrovirus group W, member 1 7 92468380-92477986 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 11 placenta: 77.1 testis: 6.7 TRIM64 C11orf28, TRIM64A ENSG00000204450 Tripartite motif containing 64 11 89968502-89975228 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045370 Approved Tissue enriched 11 placenta: 1.1 adipose tissue: 0.0 SLC13A4 SUT-1, SUT1 ENSG00000164707 Solute carrier family 13 (sodium/sulfate symporter), member 4 7 135681237-135729258 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA048582 Approved Tissue enriched 10 placenta: 76.2 testis: 7.3 MAGEA8 CT1.8, MAGE8, MGC2182 ENSG00000156009 Melanoma antigen family A8 X 149881141-149885835 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA003998 Supported Tissue enriched 9 placenta: 18.8 testis: 2.0 ADAM12 MCMPMltna, MLTN ENSG00000148848 ADAM metallopeptidase domain 12 10 126012381-126388455 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030866, HPA030867, HPA030868 Supported Supported Plasma membrane Tissue enriched 8 placenta: 236.1 cervix: 29.5 EBI3 ENSG00000105246 Epstein-Barr virus induced 3 19 4229498-4237531 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046635 Supported Tissue enriched 8 placenta: 208.2 spleen: 26.5 FBN2 CCA, DA9 ENSG00000138829 Fibrillin 2 5 128257909-128659185 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012853, CAB026401 Supported Approved Nucleoplasm
Cytosol Tissue enriched 8 placenta: 117.6 testis: 13.8 FLT1 FLT, VEGFR1 ENSG00000102755 Fms-related tyrosine kinase 1 13 28300344-28495128 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011740, HPA014290, CAB068189, CAB068190 Supported Supported Plasma membrane
Actin filaments Tissue enriched 8 placenta: 617.5 thyroid gland: 81.7 FOXI3 ENSG00000214336 Forkhead box I3 2 88446787-88452656 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 8 placenta: 7.3 testis: 0.8 HAPLN1 CRTL1 ENSG00000145681 Hyaluronan and proteoglycan link protein 1 5 83637805-83721613 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019105, HPA019482 Supported Supported Vesicles Tissue enriched 8 placenta: 102.5 cerebral cortex: 12.8 MEST PEG1 ENSG00000106484 Mesoderm specific transcript 7 130486171-130506296 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA005623 Approved Golgi apparatus
Cytosol Tissue enriched 8 placenta: 1079.4 adipose tissue: 131.7 PAPPA2 PAPP-A2, PAPPE, PLAC3 ENSG00000116183 Pappalysin 2 1 176463171-176845605 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018412, HPA018430 Supported Approved Endoplasmic reticulum
Vesicles Tissue enriched 8 placenta: 82.1 cervix: 10.8 PHLDA2 BWR1C, HLDA2, IPL, TSSC3 ENSG00000181649 Pleckstrin homology-like domain, family A, member 2 11 2928273-2929455 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003994 Uncertain Nucleoli Tissue enriched 8 placenta: 54.3 stomach: 6.8 PAPPA ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1 ENSG00000182752 Pregnancy-associated plasma protein A, pappalysin 1 9 116153804-116402322 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001667, CAB016724 Supported Uncertain Plasma membrane
Cytosol Tissue enriched 7 placenta: 103.9 parathyroid gland: 14.6 SERPINE2 GDN, nexin, PI7, PN1, PNI ENSG00000135919 Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 2 223975112-224039319 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 7 placenta: 1612.5 cerebral cortex: 236.5 CLEC1A CLEC1, MGC34328 ENSG00000150048 C-type lectin domain family 1, member A 12 10069554-10111627 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 6 placenta: 70.5 lung: 12.7 COL11A1 CO11A1, COLL6, STL2 ENSG00000060718 Collagen, type XI, alpha 1 1 102876467-103108496 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058335 Supported Endoplasmic reticulum Tissue enriched 6 placenta: 27.9 gallbladder: 4.7 EPYC DSPG3, Pg-Lb, SLRR3B ENSG00000083782 Epiphycan 12 90963679-91005026 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA038212, HPA045455 Approved Tissue enriched 6 placenta: 8.8 endometrium: 1.5 GNGT1 GNG1 ENSG00000127928 Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 7 93591573-93911265 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042721 Supported Tissue enriched 6 placenta: 3.9 urinary bladder: 0.6 GPC3 DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1 ENSG00000147257 Glypican 3 X 133535745-133985895 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006316 Approved Plasma membrane Tissue enriched 6 placenta: 838.1 lung: 130.8 SKP2 FBL1, FBXL1, p45 ENSG00000145604 S-phase kinase-associated protein 2, E3 ubiquitin protein ligase 5 36151989-36184319 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013491, CAB013533, HPA051196, HPA054633 Approved Supported Nucleus
Cytosol Tissue enriched 6 placenta: 83.9 lymph node: 13.9 WNT3A ENSG00000154342 Wingless-type MMTV integration site family, member 3A 1 228007051-228061260 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA066281 Approved Vesicles Tissue enriched 6 placenta: 23.0 lung: 3.9 BMP5 ENSG00000112175 Bone morphogenetic protein 5 6 55753645-55875564 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 5 placenta: 101.7 prostate: 20.2